Biomarker glycan

Show results for

Unknown (286)
Proteomics (83)
Genomics (24)
Transcriptomics (6)
Metabolomics (3)

Organisms

Homo sapiens (48)
Aerococcus urinae NBRC 15544 = CCUG 36881 (32)
Allexis (32)
Beta vulgaris subsp. vulgaris (32)
Canis lupus familiaris (32)
Carya cathayensis (32)
Clostridioides difficile 630 (32)
Cyanophora paradoxa (32)
Ensifer adhaerens (32)
Enterococcus faecalis (32)
Globicatella sanguinis (32)
Histomonas meleagridis (32)
Human immunodeficiency virus 1 (32)
Leishmania major strain Friedlin (32)
Mus musculus (17)
Dermestes lardarius (16)
Senegalia senegal (16)
Frangula alnus (16)
Rhodotorula (16)
Pandalus borealis (16)
Pachymenia carnosa (16)
Bothrops moojeni (16)
Quercus alba (16)
Megathura crenulata (16)
Gossypium hirsutum (16)
Bos taurus (16)
Gallus gallus (16)
Ovis aries (16)
Medicago sativa (10)
Xenopus laevis (1)

Organisms

Homo sapiens (19)
Mus musculus (1)

Repository

pride (32)
ENA (23)
geo (20)
biostudies-arrayexpress (19)
MassIVE (8)
iProX (6)
jPOST (4)
MetaboLights (3)
EGA (1)

Tissue

Blood serum (10)
Blood plasma (9)
Blood cell (4)
Epithelial cell (4)
Cell culture (2)
Colon (2)
Liver (2)
Ascites (1)
Blood (1)
Cerebrospinal fluid (1)
Fibroblast (1)
Hepatocyte (1)
Podocyte (1)
Uterus (1)

Disease

Colon cancer (2)
Hepatocellular carcinoma (2)
Cardiovascular system disease (1)
Chronic obstructive pulmonary disease (1)
Congenital disorder of glycosylation (1)
Congenital disorder of glycosylation Iq (1)
Congenital disorder of glycosylation type I (1)
Endometrial cancer (1)
Mild cognitive impairment (1)
Multiple sclerosis (1)
Non-small cell lung carcinoma (1)
Oral squamous cell carcinoma (1)
Ovarian cancer (1)
Ovary epithelial cancer (1)
Stomach carcinoma (1)
Type 2 diabetes mellitus (1)

Technology Type

Mass Spectrometry (32)
Shotgun proteomics (13)
Bottom-up proteomics (9)
Data-dependent acquisition (7)
Mass spectrometry (3)
Affinity purification coupled with mass spectrometry proteomics (2)
All-ion fragmentation (2)
Mass spectrometry imaging (2)
Data-independent acquisition (1)
Gel-based experiment (1)
SRM/MRM (1)

Instrument Platform

Orbitrap Eclipse (2)
Orbitrap Exploris 480 (2)
6490 Triple Quadrupole LC/MS (1)
6520A Quadrupole Time-of-Flight LC/MS (1)
LTQ Orbitrap Elite (1)
Orbitrap HFX (1)
TimsTOF HT (1)
TimsTOF Pro (1)
Matrix-assisted laser desorption-ionisation imaging MS - (1)
Gas Chromatography MS - positive (1)
Liquid Chromatography MS - positive - reverse phase (1)
Liquid Chromatography MS - negative - reverse phase (1)

Publication Date

2015 (17)
2013 (17)
2025 (16)
2023 (12)
2024 (8)
2026 (5)
2022 (4)
2020 (4)
2021 (3)
2016 (2)
2011 (1)
2017 (1)
2019 (1)

CHEBI ID

CHEBI:33946 (2)
CHEBI:24266 (2)
CHEBI:15620 (2)
CHEBI:28718 (2)
CHEBI:30805 (2)
CHEBI:26984 (2)
CHEBI:17553 (2)
CHEBI:16450 (2)
CHEBI:48430 (2)
CHEBI:49033 (2)
CHEBI:22660 (2)
CHEBI:18257 (2)
CHEBI:16750 (2)
CHEBI:15428 (2)
CHEBI:17268 (2)
CHEBI:17821 (2)
CHEBI:1148 (2)
CHEBI:17929 (2)
CHEBI:16335 (2)
CHEBI:17568 (2)
CHEBI:18211 (2)
CHEBI:15891 (2)
CHEBI:24813 (2)
CHEBI:16704 (2)
CHEBI:17964 (2)
CHEBI:30887 (2)
CHEBI:16027 (2)
CHEBI:16919 (2)
CHEBI:17596 (2)
CHEBI:15756 (2)

Metabolite Name

Erythrose (2)
L-Allothreonine (2)
N-Ethylglycine (2)
4',7-dihyroxyflavanone (liquiritigenin) (1)
Fructose 2,6-biphosphate degr prod (1)
Allose (1)
Bis(2-hydroxypropyl)amine (1)
3-Methylamino-1,2-propanediol (1)
Benzamide (1)
Oxamide (1)
Threo-beta-hyrdoxyaspartate (1)
10(S),17(S)-DiHDoHE (1)
Phenylphosphoric acid (1)
4-Acetylbutyric acid (1)
5-Hydroxyfluvastatin (1)
Gentisic acid (1)
D-manno-2-Heptulose (1)
Tri-glyceride (1)
Ribose-5-phosphate (1)
L-Sorbinose (1)
Trans-Aconitic acid (1)
D-gamma-Glutamyl-D-glutamic acid (1)
Alpha-D-Glucose 1,6-Bisphosphate (1)
(-)-3-Isothujone (1)
2-Amino-4-oxopentanoic acid (1)
Chenodeoxycholylglycine (1)
12'-Apo-b-carotene-3,12'-diol (1)
3-ureido-isobutyrate (1)
Methylone (1)
D-Glucosaminide (1)

First Public Date

2015 (8)
2014 (8)
2022 (2)
2025 (1)
2024 (1)
2023 (1)
2021 (1)
2017 (1)

Study type

Proteomic profiling by array (17)
Transcription profiling by array (2)

Release Date

2025 (31)
2024 (31)
2023 (31)
2021 (30)
2022 (25)
2015 (23)
2020 (20)
2013 (17)
2019 (17)
2017 (17)
2016 (17)
2018 (14)
2012 (11)
2014 (6)
2011 (5)
2026 (5)
2010 (3)
2009 (1)
2008 (1)

Lab affiliation

Chinese Academy of Sciences Shanghai Institute of Materia Medica (2)
Mayo Clinic (2)
Akhilesh Pandey, M.D., Ph.D. Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota 55905, United States (1)
Cold Spring Harbor Laboratory ( lab head ) (1)
College of Life Science, Northwest University (1)
Core Facility for Omics Sciences, IRCCS Istituto Giannina Gaslini, Genoa, Italy (1)
Dalian Institute of Chemical Physics, CAS (1)
Department of Biomedical Engineering, College of Life Science and Technology, Huazhong University of Science and Technology, N0. 1037 Luoyudong Road, Hongshan District, Wuhan 430074 (1)
Department of Cellular and Molecular Medicine, University of Copenhagen (1)
Department of Laboratory Medicine and Pathology Mayo Clinic Rochester Minnesota (1)
Department of Laboratory Medicine and Pathology Mayo Clinic, Rochester, Minnesota 55905 United States (1)
Department of Laboratory Medicine, Institute of Biomedicine, University of Gothenburg, Gothenburg, Sweden (1)
Department of Laboratory Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology (1)
Faculty of Pharmacy and Biochemistry, University of Zagreb (1)
Future Industries Institute, Mawson Lakes Campus, University of South Australia, Adelaide, South Australia, 5095 (1)
Georgetown University Medical Center (1)
Graduate Institute of Anatomy and Cell Biology, College of Medicine, National Taiwan University. Taipei, Taiwan (1)
Hematology and Transfusion Medicine, Department of Laboratory Medicine, Lund University, Lund, Sweden (1)
Institute for Glyco-core Research (iGCORE), Nagoya University, Aichi, Japan (1)
Medical University of South Carolina, Department of Cell and Molecular Pharmacology, Charleston, SC 29425, United States (1)
Proteomics unit (PROBE), Department of Biomedicine, University of Bergen, Norway (1)
Sichuan University,West China Hospital (1)
State Key Laboratory of Common Mechanism Research for Major Disease, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China. (1)
Texas Tech University (1)
Translational Metabolic Laboratory, Department of Laboratory Medicine, Radboud Institute for Molecular Life Sciences, Radboud university medical center, Nijmegen, The Netherlands (1)
Translational Metabolic Laboratory, Department of Laboratory Medicine, Radboudumc, Nijmegen, The Netherlands (1)
UC Davis Proteomics Core (1)
University of Zagreb Faculty of Pharmacy and Biochemistry (1)
West China Hospital, Sichuan University (1)
Yale University Chemistry Department (1)

Tags

xref:PubMed:23362327 (8)
xref:PubMed:30135430 (1)
xref:PubMed:37132100 (1)
xref:PubMed:33093149 (1)

Previous page
1 / 41
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 41
Next page

Sort by:

Relevance

Page size

Baseline serum anti-glycan antibodies of 113 subjects in a clinical trial of PROSTVAC-VF, a therapeutic cancer vaccine [Validation IgG 1:50]

Purpose: There is evidence that therapeutic cancer vaccines can lengthen survival for some cancer patients, but responses vary widely from one person to another. Methods to predict clinical outcomes will advance the field and provide new insights into critical determinants of in vivo efficacy. Thi...

ORGANISM(S): Homo sapiens

2013-04-01 | E-GEOD-42163 | biostudies-arrayexpress

Baseline serum anti-glycan antibodies of 113 subjects in a clinical trial of PROSTVAC-VF, a therapeutic cancer vaccine [Validation IgM 1:50]

ORGANISM(S): Homo sapiens

2013-04-01 | E-GEOD-42175 | biostudies-arrayexpress

Baseline serum anti-glycan antibodies of 113 subjects in a clinical trial of PROSTVAC-VF, a therapeutic cancer vaccine [Validation Total Ig 1:50]

ORGANISM(S): Homo sapiens

2013-04-01 | E-GEOD-42176 | biostudies-arrayexpress

Baseline serum anti-glycan antibodies of 113 subjects in a clinical trial of PROSTVAC-VF, a therapeutic cancer vaccine [Validation Total Ig 1:200]

ORGANISM(S): Homo sapiens

2013-04-01 | E-GEOD-42179 | biostudies-arrayexpress

Baseline serum anti-glycan antibodies of 28 subjects in a clinical trial of PROSTVAC-VF, a therapeutic cancer vaccine [Training IgG 1:50]

ORGANISM(S): Homo sapiens

2013-04-01 | E-GEOD-42019 | biostudies-arrayexpress

Baseline serum anti-glycan antibodies of 28 subjects in a clinical trial of PROSTVAC-VF, a therapeutic cancer vaccine [Training IgM 1:50]

ORGANISM(S): Homo sapiens

2013-04-01 | E-GEOD-42020 | biostudies-arrayexpress

Baseline serum anti-glycan antibodies of 28 subjects in a clinical trial of PROSTVAC-VF, a therapeutic cancer vaccine [Training Total Ig 1:50]

ORGANISM(S): Homo sapiens

2013-04-01 | E-GEOD-42145 | biostudies-arrayexpress

Baseline serum anti-glycan antibodies of 28 subjects in a clinical trial of PROSTVAC-VF, a therapeutic cancer vaccine [Training Total Ig 1:200]

ORGANISM(S): Homo sapiens

2013-04-01 | E-GEOD-42150 | biostudies-arrayexpress

Detection of Chemotherapy-Resistant Pancreatic Cancer Using a Glycan Biomarker

PRJNA611767 | ENA

Diagnostic Potential of Plasma IgG N-glycans in Discriminating Thyroid Cancer from Benign Thyroid Nodules and Healthy Controls

BACKGROUND: Novel biomarkers are urgently needed to distinguish between benign and malignant thyroid nodules and detect thyroid cancer in the early stage. The associations between serum IgG N-glycosylation and thyroid cancer risk have been revealed. We aimed to explore the potent...

2021-09-01 | MTBLS2935 | MetaboLights

Previous page
1 / 41
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 41
Next page

Sort by:

Relevance

Page size

402 Results

Show results for

Organisms

Organisms

Repository

Tissue

Disease

Technology Type

Instrument Platform

Publication Date

CHEBI ID

Metabolite Name

First Public Date

Study type

Release Date

Lab affiliation

Tags

OmicsDI is part of the ELIXIR infrastructure

Tweets